PK/PD investigation of antiviral host matriptase/TMPRSS2 inhibitors in cell models

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: PK/PD investigation of antiviral host matriptase/TMPRSS2 inhibitors in cell models ; volume:14 ; number:1 ; day:18 ; month:7 ; year:2024 ; pages:1-14 ; date:12.2024
Scientific reports ; 14, Heft 1 (18.7.2024), 1-14, 12.2024

Creator: Gamba, Dávid
Eijk, Nicholas van
Lányi, Katalin
Monostory, Katalin
Steinmetzer, Torsten
Marosi, András
Rácz, Anita
Bajusz, Dávid
Kruhl, Diana
Böttcher-Friebertshäuser, Eva
Pászti-Gere, Erzsébet

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-024-67633-2

URN: urn:nbn:de:101:1-2410080805041.867508377268

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:29 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Gamba, Dávid
Eijk, Nicholas van
Lányi, Katalin
Monostory, Katalin
Steinmetzer, Torsten
Marosi, András
Rácz, Anita
Bajusz, Dávid
Kruhl, Diana
Böttcher-Friebertshäuser, Eva
Pászti-Gere, Erzsébet
SpringerLink (Online service)

Other Objects (12)

In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis

TMPRSS2, a novel host-directed drug target against SARS-CoV-2

DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity

Pharmacodynamics (PD), Pharmacokinetics (PK) and PK-PD Modeling of NRF2 Activating Dietary Phytochemicals in Cancer Prevention and in Health

Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets

Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats

PK/PD modeling supports the dose-escalation decision in VIKING

TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells

Schriftgut

Bereich Produktion Arbeitspläne, Kader, Kollekt. Ausarbeitungen von PP PV PD PK

Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation

BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry

In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis

TMPRSS2, a novel host-directed drug target against SARS-CoV-2

DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity

Pharmacodynamics (PD), Pharmacokinetics (PK) and PK-PD Modeling of NRF2 Activating Dietary Phytochemicals in Cancer Prevention and in Health

Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets

Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats

PK/PD modeling supports the dose-escalation decision in VIKING

TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells

Schriftgut

Bereich Produktion Arbeitspläne, Kader, Kollekt. Ausarbeitungen von PP PV PD PK

Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation

BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry

In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis

TMPRSS2, a novel host-directed drug target against SARS-CoV-2

DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity

Pharmacodynamics (PD), Pharmacokinetics (PK) and PK-PD Modeling of NRF2 Activating Dietary Phytochemicals in Cancer Prevention and in Health

Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets

Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats

PK/PD modeling supports the dose-escalation decision in VIKING

TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells

Schriftgut

Bereich Produktion Arbeitspläne, Kader, Kollekt. Ausarbeitungen von PP PV PD PK

Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation

BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

PK/PD investigation of antiviral host matriptase/TMPRSS2 inhibitors in cell models

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis

TMPRSS2, a novel host-directed drug target against SARS-CoV-2

DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity

Pharmacodynamics (PD), Pharmacokinetics (PK) and PK-PD Modeling of NRF2 Activating Dietary Phytochemicals in Cancer Prevention and in Health

Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets

Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats

PK/PD modeling supports the dose-escalation decision in VIKING

TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells

Bereich Produktion Arbeitspläne, Kader, Kollekt. Ausarbeitungen von PP PV PD PK

Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation

BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry

BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry

In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis

TMPRSS2, a novel host-directed drug target against SARS-CoV-2

DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity

Pharmacodynamics (PD), Pharmacokinetics (PK) and PK-PD Modeling of NRF2 Activating Dietary Phytochemicals in Cancer Prevention and in Health

Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets

Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats

PK/PD modeling supports the dose-escalation decision in VIKING

TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells

Bereich Produktion Arbeitspläne, Kader, Kollekt. Ausarbeitungen von PP PV PD PK

Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation

BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry

BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry

In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis

TMPRSS2, a novel host-directed drug target against SARS-CoV-2

DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity

Pharmacodynamics (PD), Pharmacokinetics (PK) and PK-PD Modeling of NRF2 Activating Dietary Phytochemicals in Cancer Prevention and in Health

Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets

Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats

PK/PD modeling supports the dose-escalation decision in VIKING

TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells

Bereich Produktion Arbeitspläne, Kader, Kollekt. Ausarbeitungen von PP PV PD PK

Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation

BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry

BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry

Related objects

Reset password